Concepedia
Statistics
Publications
21
Citations
896
H-Index
16
Active since
1996
Affiliations
AstraZeneca (United Kingdom)(Current)
AstraZeneca (United States)
University of Massachusetts Amherst
AstraZeneca (Sweden)
Roland Hill (United Kingdom)
Matthew Skinner is an author at AstraZeneca (United Kingdom) specializing in pharmacology, medicine, and pharmacodynamics.
Publications per year
1996–2021
From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients
H‐G Eichler, LG Baird, Richard Barker et al. · Clinical Pharmacology & Therapeutics · 2015 · 187 citations · Full text
Pharmacy, Pharmaceutical Policy, Drug Approval Processes +15
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
Claire Patterson, Srividya B. Balachander, Iain Grant et al. · Communications Biology · 2021 · 95 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +14
Studies on the roles of ATP, adenosine and nitric oxide in mediating muscle vasodilatation induced in the rat by acute systemic hypoxia.
Matthew Skinner, Janice M. Marshall · The Journal of Physiology · 1996 · 75 citations · Full text
Medicine, Pharmacology, Physiology +17
Can non‐clinical repolarization assays predict the results of clinical thorough QT studies? Results from a research consortium
Eun‐Jung Park, Gary A. Gintant, Daoqin Bi et al. · British Journal of Pharmacology · 2017 · 67 citations · Full text
Medicine, Cardiology, Pharmacology +17
An Analysis of the Relationship Between Preclinical and Clinical QT Interval-Related Data
Christopher E. Pollard, Matthew Skinner, Stanley E. Lazic et al. · Toxicological Sciences · 2017 · 57 citations · Full text
Medicine, Cardiology, Pharmacology +14
1–5 of 21